BECTON DICKINSON & CO

Becton, Dickinson and Company (BD) is a global medical technology company incorporated in New Jersey in 1906. Its executive offices are located in Franklin Lakes, New Jersey. BD produces a broad range of medical technologies and devices used in healthcare institutions, physicians' offices, laboratories, and clinics. The company's business strategy is focused on improving medication management and patient safety, supporting infection prevention practices, equipping surgical and interventional procedures, improving drug delivery, aiding anesthesiology care, enhancing the diagnosis of infectious diseases and cancers, and advancing cellular research and applications. BD's operations consist of three worldwide business segments: BD Medical, BD Life Sciences, and BD Interventional. BD Medical produces a broad array of medical technologies and devices used to help improve healthcare delivery in various settings. BD Life Sciences provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections, and cancers. BD Interventional provides vascular, urology, oncology, and surgical specialty products intended to be used once or temporarily/permanently implanted. BD's website is bd.com, and its common stock is traded on the New York Stock Exchange under the ticker symbol BDX. The company has completed several acquisitions and divestitures in recent years, including the acquisition of Parata Systems in 2022 and the sale of the Surgical Instrumentation platform in 2023. BD's products are marketed and distributed through independent distribution channels, as well as directly to hospitals and other healthcare related institutions. The company conducts its research and development activities at various locations worldwide and owns significant intellectual property, including patents, patent applications, technology, trade secrets, know-how, copyrights, and trademarks. BD competes in the medical technology marketplace based on factors such as price, quality, innovation, service, reputation, distribution, and promotion.